Samjo Management LLC Sells 61,050 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• Samjo Management LLC sold 61,050 shares of Aspen Aerogels, reducing its stake by 7% to 813,600 shares, which represents 2.2% of its investment portfolio.
• Several major investors, including Vanguard Group Inc. and Millennium Management LLC, adjusted their holdings in Aspen Aerogels, indicating ongoing institutional interest.
• Aspen Aerogels' stock faces mixed analyst ratings, with a current consensus of "Moderate Buy" and a price target of $19.50, despite recent downgrades from firms like Oppenheimer and Barclays.

Samjo Management LLC lessened its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 7.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 813,600 shares of the construction company's stock after selling 61,050 shares during the period. Aspen Aerogels accounts for 2.2% of Samjo Management LLC's investment portfolio, making the stock its 13th largest position. Samjo Management LLC owned about 0.99% of Aspen Aerogels worth $5,199,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Aspen Aerogels by 0.3% during the first quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company's stock valued at $27,944,000 after purchasing an additional 12,913 shares during the last quarter. Oaktop Capital Management II L.P. raised its position in shares of Aspen Aerogels by 5.6% in the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock valued at $44,437,000 after purchasing an additional 200,000 shares during the period. Needham Investment Management LLC raised its position in shares of Aspen Aerogels by 5.2% in the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company's stock valued at $28,390,000 after purchasing an additional 117,500 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Aspen Aerogels by 25.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock valued at $23,983,000 after buying an additional 409,862 shares in the last quarter. Finally, Millennium Management LLC boosted its holdings in Aspen Aerogels by 4,757.8% in the 4th quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company's stock worth $19,270,000 after buying an additional 1,588,632 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price objective for the stock from $7.00 to $16.00 in a research report on Monday, August 11th. Finally, Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.50.

Aspen Aerogels Price Performance

ASPN stock opened at $6.9750 on Friday. The firm has a 50 day simple moving average of $6.91 and a two-hundred day simple moving average of $6.79. The stock has a market cap of $574.46 million, a PE ratio of -1.83 and a beta of 2.73. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $32.31. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million during the quarter, compared to the consensus estimate of $72.53 million. During the same period in the previous year, the firm posted $0.21 EPS. The firm's revenue was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. On average, analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Activity

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the transaction, the chief accounting officer directly owned 19,879 shares in the company, valued at approximately $145,315.49. This represents a 18.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.30% of the company's stock.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.